Enasidenib - HY-18690
Nur noch %1 verfügbar
Catalog #
HY-18690
Ab
52,00 €
Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-18690/Enasidenib-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | AG-221 |
| CAS | 1446502-11-9 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 473.38 |
| Solubility | DMSO : 50 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Isocitrate Dehydrogenase (IDH) |
| Application: | Cancer-programmed cell death |
|---|